Contributions of caspase-8 and -9 to liver injury from CYP2E1-produced metabolites of halogenated hydrocarbons. (2nd January 2018)
- Record Type:
- Journal Article
- Title:
- Contributions of caspase-8 and -9 to liver injury from CYP2E1-produced metabolites of halogenated hydrocarbons. (2nd January 2018)
- Main Title:
- Contributions of caspase-8 and -9 to liver injury from CYP2E1-produced metabolites of halogenated hydrocarbons
- Authors:
- Ijiri, Yoshio
Kato, Ryuji
Sadamatsu, Maiko
Takano, Mina
Yasuda, Yuki
Tanaka, Fumiaki
Oishi, Chiyo
Imano, Hideki
Okada, Yoshikatsu
Tanaka, Kazuhiko
Hayashi, Tetsuya - Abstract:
- Abstract: 1. Drug-induced liver injury is difficult to predict at the pre-clinical stage. This study aimed to clarify the roles of caspase-8 and -9 in CYP2E1 metabolite-induced liver injury in both rats and cell cultures in vitro treated with carbon tetrachloride (CCl4 ), halothane or sevoflurane. The human hepatocarcinoma functional liver cell line was maintained in 3-dimensional culture alone or in co-culture with human acute monocytic leukemia cells. 2. In vivo, laboratory indices of liver dysfunction and histology were normal after administration of sevoflurane. CCl4 treatment increased blood AST/ALT levels, liver caspase-3 and -9 activities and liver malondialdehyde, accompanied by centrilobular hepatocyte necrosis. Halothane increased AST/ALT levels, caspase-3 and -8 activities (but not malondialdehyde) concomitant with widespread hepatotoxicity. In vitro, CCl4 treatment increased caspase-9 activity and decreased both mitochondrial membrane potential (MMP) and cell viability. In co-culture, halothane increased caspase-8 activity and decreased MMP and cellular viability. There were no toxic responses in CYP2E1 knockdown in monoculture and co-culture. 3. CYP2E1-inducing compounds play a pivotal role in halogenated hydrocarbon toxicity. 4. Changes in hepatocyte caspase-8 and -9 activities could be novel biomarkers of metabolites causing DILI, and in pre-clinical development of new pharmaceuticals can predict nascent DILI in the clinical stage.
- Is Part Of:
- Xenobiotica. Volume 48:Number 1(2018:Jan.)
- Journal:
- Xenobiotica
- Issue:
- Volume 48:Number 1(2018:Jan.)
- Issue Display:
- Volume 48, Issue 1 (2018)
- Year:
- 2018
- Volume:
- 48
- Issue:
- 1
- Issue Sort Value:
- 2018-0048-0001-0000
- Page Start:
- 60
- Page End:
- 72
- Publication Date:
- 2018-01-02
- Subjects:
- Caspase-8 -- caspase-9 -- CYP2E1 knockdown -- CYP2E1 metabolite-induced liver injury -- FLC-4 -- three-dimensional culture
Metabolism -- Periodicals
Drugs -- Physiological effect -- Periodicals
Food additives -- Periodicals
Chemicals -- Physiological effect -- Periodicals
Biochemistry -- Periodicals
Pharmaceutical Preparations -- metabolism -- Periodicals
Metabolism -- Periodicals
574.133 - Journal URLs:
- http://informahealthcare.com/journal/xen ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/00498254.2016.1275881 ↗
- Languages:
- English
- ISSNs:
- 0049-8254
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9367.020000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 5447.xml